We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$218B
AUM Growth
-$5.41B
Cap. Flow
-$25.1B
Cap. Flow %
-11.51%
Top 10 Hldgs %
47.1%
Holding
5,603
New
345
Increased
2,379
Reduced
1,667
Closed
541

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.82B
2
AAPL icon
Apple
AAPL
+$1.62B
3
UNH icon
UnitedHealth
UNH
+$1.03B
4
XOM icon
ExxonMobil
XOM
+$869M
5
TSLA icon
Tesla
TSLA
+$701M

Sector Composition

Rank Sector Weight
1 Technology 12.19%
2 Consumer Discretionary 5.03%
3 Healthcare 4.78%
4 Financials 4.74%
5 Communication Services 2.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DJT icon
4476
Trump Media & Technology Group
DJT
$2.73B
$21.1K ﹤0.01%
1,500
GEL icon
4477
Genesis Energy
GEL
$1.87B
$21.1K ﹤0.01%
1,871
-17,763
-90% -$200K
SLDB icon
4478
Solid Biosciences
SLDB
$794M
$20.9K ﹤0.01%
4,417
-20
-0.5% -$120
ARL icon
4479
American Realty Investors
ARL
$246M
$20.8K ﹤0.01%
790
+389
+97% +$9.92K
LCTX icon
4480
Lineage Cell Therapeutics
LCTX
$269M
$20.7K ﹤0.01%
13,830
-14,279
-51% -$19.9K
KLTR icon
4481
Kaltura
KLTR
$206M
$20.7K ﹤0.01%
10,798
-20,569
-66% -$40.4K
WDAY icon
4482
CALL
Workday
WDAY
$39.6B
$20.7K ﹤0.01%
100
-61,900
-100% -$11.3M
SURF
4483
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$20.4K ﹤0.01%
29,251
-78,066
-73% -$63.3K
LVLU icon
4484
Lulu's Fashion Lounge
LVLU
$46.6M
$20.4K ﹤0.01%
571
+273
+92% +$11.5K
TRKA
4485
DELISTED
Troika Media Group, Inc. Common Stock
TRKA
$20.1K ﹤0.01%
3,320
CELU icon
4486
Celularity
CELU
$18.4M
$20K ﹤0.01%
3,234
+1,529
+90% +$12.3K
KARO icon
4487
Karooooo
KARO
$1.98B
$19.9K ﹤0.01%
857
-13,463
-94% -$331K
BVS icon
4488
Bioventus
BVS
$892M
$19.8K ﹤0.01%
18,524
+9,945
+116% +$19K
PRAX icon
4489
Praxis Precision Medicines
PRAX
$8.58B
$19.6K ﹤0.01%
1,611
+908
+129% +$38.3K
ONDS icon
4490
Ondas Inc
ONDS
$4.27B
$19.4K ﹤0.01%
17,960
+8,405
+88% +$14.6K
CURE icon
4491
Direxion Daily Healthcare Bull 3X ETF
CURE
$178M
$19.2K ﹤0.01%
200
ONC
4492
BeOne Medicines Ltd
ONC
$32.8B
$19.2K ﹤0.01%
89
-2,911
-97% -$698K
TLSA icon
4493
Tiziana Life Sciences
TLSA
$131M
$19.1K ﹤0.01%
17,500
EIGR
4494
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$19.1K ﹤0.01%
709
-53,139
-99% -$2.47M
NTCO
4495
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$18.8K ﹤0.01%
3,600
GRC icon
4496
Gorman-Rupp
GRC
$2.14B
$18.4K ﹤0.01%
+736
New +$19.6K
ROOT icon
4497
Root
ROOT
$857M
$18.2K ﹤0.01%
4,038
+1,954
+94% +$9.9K
EEX
4498
DELISTED
Emerald Holding
EEX
$17.8K ﹤0.01%
4,794
-5,202
-52% -$19.4K
WEJO
4499
DELISTED
Wejo Group Limited Common Shares
WEJO
$17.8K ﹤0.01%
36,006
+20,587
+134% +$12.9K
XP icon
4500
XP
XP
$8.81B
$17.5K ﹤0.01%
1,476

Similar funds

Barclays's Q1 2023 Portfolio in Review

As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.

  • Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
  • Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
  • Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
  • Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
  • Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
  • Barclays opened 345 new positions and closed 541 in Q1 2023.
  • Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.